Vinva Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.2M Buy
+41,681
New +$15.5M 0.11% 172
2025
Q4
Sell
-3,209
Closed -$1.03M 422
2025
Q3
$1.03M Sell
3,209
-3,569
-53% -$1.11M 0.02% 317
2025
Q2
$2.59M Sell
6,778
-4,655
-41% -$1.87M 0.07% 219
2025
Q1
$4.94M Buy
11,433
+6,979
+157% +$2.8M 0.2% 131
2024
Q4
$1.64M Sell
4,454
-3,975
-47% -$1.66M 0.06% 245
2024
Q3
$4.42M Sell
8,429
-36
-0.4% -$19.2K 0.19% 127
2024
Q2
$4.54M Buy
8,465
+197
+2% +$104K 0.23% 110
2024
Q1
$4.29M Buy
8,268
+165
+2% +$82.1K 0.24% 109
2023
Q4
$3.8M Buy
8,103
+1,099
+16% +$508K 0.26% 95
2023
Q3
$3.13M Sell
7,004
-170
-2% -$77.1K 0.29% 81
2023
Q2
$3.16M Sell
7,174
-1,008
-12% -$465K 0.27% 92
2023
Q1
$3.75M Buy
+8,182
New +$3.89M 0.31% 84

Other funds holding ELV

Vinva Investment Management's ELV Position: Q2 2026 in Review

Vinva Investment Management opened a new position in Elevance Health (ELV) in Q2 2026: 41,681 shares worth $16.2M. The stake represents 0.11% of the portfolio and ranks #172 among its holdings. This is a return to the name: Vinva Investment Management previously reported a position in ELV as recently as Q3 2025.

Vinva Investment Management first reported a position in ELV in Q1 2023 and has held it in 12 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Vinva Investment Management held 41,681 shares of Elevance Health worth $16.2M as of Q2 2026.
  • Elevance Health was a new Vinva Investment Management position in Q2 2026.
  • Elevance Health made up 0.11% of Vinva Investment Management's portfolio in Q2 2026, its #172 holding.
  • Vinva Investment Management first reported a position in Elevance Health in Q1 2023 and has held it in 12 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Vinva Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.